GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (AGTC), President and Chief Executive Officer, Sue Washer, sent the following letter ...
If you want to know who really controls Applied Genetic Technologies Corporation (NASDAQ:AGTC), then you'll have to look at the makeup of its share registry. Generally speaking, as a company grows, ...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...
Applied Genetic Technologies (AGTC) is a pre-clinical-stage biotechnology company headquartered in Alachua, FL. Ten other companies are scheduled for the week of March 24, 2014. The full IPO calendar ...
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick ...
Applied Genetic Technologies (AGTC) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from ...
Applied Genetic Technologies, an Alachua, Fla., gene-therapy developer, received a $2 million milestone payment from Genzyme. The two companies are jointly developing a gene therapy for treating a ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results